Skip to main content

Table 3 Outcomes of tracing of the 136 ART-eligible patients who were considered lost to follow-up and not known to have died

From: Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa

Results

No.

Did not complete ART preparation because of "disclosure" issue

54 (40%)

Subject has relocated out of The Gambia

11 (8%)

Receiving care in another health care facility

4 (3%)

Has opted for traditional treatment

4 (3%)

"Don't want Antiretroviral therapy"

14 (10%)

Not found at field visit

35 (26%)

Subject gave no reason but refused to attend clinic

14 (10%)